In this present study, we evaluated the antiproliferative activity of these small-molecule compounds against two different human isocitrate dehydrogenase (IDH)-wildtype subtype glioblastoma cell lines, U87 and LN229, and found that compound-1H exhibited better anticancer potential. Here, IDH3A is linked to glioblastoma.